Depertment of Nephrology, Shizuoka General Hospital, Japan.
Graduate School of Public Health, Shizuoka Graduate University of Public Health, Japan.
Intern Med. 2024 Oct 15;63(20):2833-2837. doi: 10.2169/internalmedicine.3082-23. Epub 2024 Mar 4.
Tosufloxacin tosilate is classified as a new quinolone antibacterial agent, which has been reported to cause crystal nephropathy. However, the origin of these crystal deposits has not yet been elucidated. We encountered a case of renal failure that progressed slowly owing to crystal-forming interstitial nephritis after long-term exposure to tosufloxacin. Mass spectrometry of the renal specimens revealed that tosufloxacin was deposited in the kidneys. The patient's renal function improved slowly with the withdrawal of tosufloxacin and steroid therapy. This is the first case to demonstrate the presence of crystal deposits consisting of tosufloxacin.
妥舒沙星甲苯磺酸盐被归类为一种新型的喹诺酮类抗菌药物,据报道可引起结晶性肾病。然而,这些晶体沉积物的来源尚未阐明。我们遇到了一例因长期接触妥舒沙星而导致结晶形成性间质性肾炎引起的进行性缓慢肾衰竭的病例。肾标本的质谱分析显示妥舒沙星在肾脏中沉积。随着妥舒沙星和类固醇治疗的停用,患者的肾功能缓慢改善。这是首例证明存在由妥舒沙星组成的晶体沉积物的病例。